UB Pharmacy showcases research and leadership at 2025 ACCP Annual Meeting

The ACCP Annual Meeting features educational sessions, networking opportunities with clinical pharmacy leaders across the country, and the latest updates on clinical practice, research and policy issues facing the profession.

At this year’s meeting, SPPS presented multiple platform sessions, research abstracts and posters and celebrated several appointments and awards.

Collin Clark, PharmD, clinical assistant professor of pharmacy practice, moderated the Geriatrics Practice and Research Network (PRN) Focus Session, Antithrombotic Management for Older Adults: Personalized Approaches to Therapy and Deprescribing. The session provided evidence-based strategies to optimize antithrombotic therapy in older adults, focusing on age-related clinical considerations following recent updates to the American Geriatrics Society Beers Criteria® and deprescribing practices for patients who may no longer benefit from treatment. Maya Chilbert, PharmD, clinical associate professor of pharmacy practice, took part in the session and presented, ‘Minimizing Harm, Maximizing Benefit: Safe Antithrombotic Therapy in Older Adults.’

Nicole Albanese, PharmD, assistant dean of student success and engagement and clinical associate professor of pharmacy practice, moderated the Endocrine and Metabolism PRN Focus Session, Beyond Type 1 and Type 2: Unveiling the Hidden Faces of Diabetes. The session broadened understanding of the diverse spectrum of diabetes types beyond commonly discussed classifications by examining their pathophysiology, diagnostic challenges and management strategies to support individualized treatment and interdisciplinary collaboration.

Calvin Meaney, PharmD, clinical associate professor of pharmacy practice, took part in the Adult Medicine PRN Focus Session, Hitting the Sweet Spot: Managing the Risks and Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in an Inpatient Population. The session addressed inpatient use of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 (GLP-1) receptor agonists for general medicine practitioners, focusing on SGLT2i use for hospitalized patients with non-diabetes indications, identifying adverse drug events and mitigating costs, and strategies to manage common clinical scenarios where newer antihyperglycemic medications are used in hospitalized patients.

Our SPPS faculty, residents and fellows presented a variety of abstracts and posters at scientific poster sessions.

• Comparison of Bleeding Rates in Inpatients with Acute Kidney Injury Maintained on Apixaban or Switched to Heparin.
• Achievement of transitions of care-related entrustable professional activities during inpatient cardiology and internal medicine rotations.
• Impact of a layered-learning practice model on inpatient glycemic management.
• Impact of Cognitive Potentially Inappropriate Medications on Healthcare Utilization and Health-Related Quality of Life in Community-Dwelling Older Adults with Cognitive Disorders.
• Pilot Study of a Pharmacist-Led Medication Reconciliation and Social Needs Screening Intervention in the Emergency Department.
• Real World Prescribing Patterns for Potentially Inappropriate Medications following the Release of the Deprescribing Guidelines: A Nationwide Cross-Sectional Study in the United States.
• Addressing Social Determinants of Health with Pharmacy Trainees on a Federally Qualified Health Center Clinical Pharmacy Consult Service.
• Characterization of Glucagon-Like Peptide-1 Receptor Agonists Use for Treatment of Type 2 Diabetes Mellitus in Under-Resourced Populations.
• Assessing Guideline Adherence in Outpatient Prescribing for Pediatric Group A Streptococcal Pharyngitis.
• Assessment of Prescribing Patterns for Outpatient Treatment of Pediatric Lyme Disease.

• Nicole Albanese, PharmD, named chair, Endocrine and Metabolism PRN.
• Gina Prescott, PharmD, director of global and community outreach and clinical professor of pharmacy practice, named chair, Publications Committee, with a focus on patient education.

• William J. Jusko, PhD, SUNY Distinguished Professor of Pharmaceutical Sciences, recipient of the ACCP 2025 Therapeutic Frontiers Lecture Award.
• Ashley Woodruff, PharmD, associate dean for professional education and clinical associate professor of pharmacy practice, named an ACCP Fellow and a 2025 Outstanding Reviewer for the Journal of the American College of Clinical Pharmacy.
• Haowen Hsu, PharmD, MPH, SPPS Medication Safety and Health Outcomes Fellow, named an ACCP Best Resident/Fellow Award finalist.

ACCP is a national professional and scientific society that provides leadership, education, advocacy and resources enabling clinical pharmacists to achieve excellence in practice, research and education.